GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $24,262,000 | +501.4% | 356,270 | +182.1% | 23.36% | +212.0% |
| Q2 2022 | $4,034,000 | -7.8% | 126,270 | 0.0% | 7.49% | +1.1% |
| Q1 2022 | $4,374,000 | +18.3% | 126,270 | 0.0% | 7.41% | +97.1% |
| Q4 2021 | $3,696,000 | +14.9% | 126,270 | 0.0% | 3.76% | +70.7% |
| Q3 2021 | $3,217,000 | -27.3% | 126,270 | 0.0% | 2.20% | -8.2% |
| Q2 2021 | $4,422,000 | -14.1% | 126,270 | 0.0% | 2.40% | +5.4% |
| Q1 2021 | $5,146,000 | -5.9% | 126,270 | 0.0% | 2.28% | +5.7% |
| Q4 2020 | $5,469,000 | – | 126,270 | – | 2.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 356,069 | $16,094,000 | 8.69% |
| Perceptive Advisors | 4,828,910 | $218,266,000 | 5.72% |
| Grace Capital | 98,939 | $13,970,000 | 5.34% |
| GREAT POINT PARTNERS LLC | 770,400 | $34,822,000 | 4.83% |
| Camber Capital Management LP | 2,200,000 | $99,440,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 602,200 | $27,219,000 | 3.77% |
| Ghost Tree Capital, LLC | 242,000 | $10,938,000 | 3.22% |
| Casdin Capital, LLC | 480,000 | $21,696,000 | 3.03% |
| NEXTHERA CAPITAL LP | 404,092 | $18,265,000 | 2.83% |
| Asymmetry Capital Management, L.P. | 49,355 | $2,231,000 | 2.19% |